Intera Partners to support the internationalisation and growth of Galena Pharma

Galena Pharma is a Finnish company specializing in product development and contract manufacturing of pharmaceuticals, medical devices and food supplements as well as their support services. The company has grown and invested strongly in recent years and now the growth story continues as the Finnish private equity investor Intera Partners becomes Galena Pharma’s co-owner.

___________________________________________________________________________

‚Deals in Europe‘

Private Equity Investments in Europe

  • 14-daily publication with ALL Private Equity Deals in Europe
  • With every ‚Deals in Europe‘ issue you will receive an update of ALL deals from the respective year as an Excel file
  • Detailed information of target, investors, buyer, seller and advisors

More information / EXAMPLE edition of ‚Deals in Europe‘

____________________________________________________________________________

Galena Pharma continues to pursuit growth with its new co-owner Intera Partners. “We want to grow in the international market in the coming years. The products we have developed and manufactured are already being exported to several countries and now, with the support of Intera Partners’ contacts and expertise, we can further support our internationalisation goals.” says Galena Pharma’s Managing Director Atte Kukkonen.

There will be a growing demand for Galena Pharma’s expertise in the future, especially in the medical device market. The level of requirements will increase, and legislation will be tightened in the coming years, which will provide international opportunities for Galena Pharma’s product development and its new innovations and services.

“Galena Pharma is a promising and successful company, and we want to support their growth. Through deep expertise and determined development, the company has become a leading player in the contract development and manufacturing (CDMO) field in Finland. With Intera’s co-ownership, Galena Pharma’s current entrepreneurs will receive even more support for internationalisation and growth,” says Arjo Laukia, a partner at Intera Partners.

Galena Pharma’s operations will continue as normal with the new co-owner, and the change will not affect the status of the company’s operational management or the personnel.
__________________________

GALENA PHARMA OY
Galena Pharma Oy is a Finnish pharmaceutical factory specialising in contract manufacturing and packaging services for pharmaceuticals and health products. Oy Galena Ltd was founded in 1996 and the company was transferred from Yliopiston Apteekit to private ownership in 2011. Today, Galena Pharma Oy employs 40 professionals. www.galena.fi

INTERA PARTNERS
Intera Partners is a Finnish growth-oriented private equity firm, that invests in Finnish and Swedish companies. Intera was founded in 2007 and is owned by its employees. Fund investors include leading Nordic and European institutional investors. www.interapartners.fi